The only FDA-approved vaccine, Dengvaxia, has limitations due to antibody-dependent enhancement (ADE), necessitating careful administration. The recent pre-approval of TAK-003 by WHO in 2024 ...
In the Philippines, the Dengvaxia controversy caused a massive drop in vaccine acceptance from 93 percent to 32 percent, with measles epidemics and outbreaks occurring since 2019 when there were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback